Source: FinanzNachrichten

CorWave: CorWave Presents an Unprecedented Chronic In Vivo Study at the 41st Annual Meeting of the International Society of Heart and Lung Transplantation

CorWave, a French medical device company committed to the fight against heart failure, unveiled an unprecedented study on the performance of its implantable heart pump at the 41st Annual Meeting o...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Louis de Lillers's photo - CEO of CorWave

CEO

Louis de Lillers

CEO Approval Rating

78/100

Read more